News

/News

Arvinas expands floor space at Science Park

Arvinas is adding 30 jobs and taking on an additional 8,500 square feet at its headquarters and research facility in Science Park in New Haven. Arvinas develops treatments for cancers and other difficult-to-treat diseases. When the company completes its current hiring, its workforce will have expanded from the 45 employees it had at the end of last year to about 75 people. more

By |January 25th, 2018|News|0 Comments

Vicki Veltri to lead CT Office of Health Strategy

Connecticut Governor Dannel P. Malloy yesterday announced that he is appointing Victoria Veltri of Colchester to serve as Executive Director of the state’s Office of Health Strategy, a new state office created through the consolidation of several existing resources. Veltri currently serves as Chief Health Policy Advisor in the Office of Lt. Governor Nancy Wyman. In this position, she coordinates the state’s healthcare reform initiatives and serves as a member of the Board of Directors for Access Health CT, the state’s healthcare exchange, as well as on the board of Connecticut Partners for Health. more

By |January 25th, 2018|News|0 Comments

Biohaven reports progress re ALS drug

Biohaven Pharmaceutical Holding Company announced positive results of its bioequivalence study of BHV-0223. The study was designed to demonstrate pharmacokinetic equivalence of the company’s sublingual drug BHV-0223 compared to the reference listed drug Rilutek (riluzole), which is currently the standard of care treatment for patients with Amyotrophic Lateral Sclerosis. more

By |January 25th, 2018|News|0 Comments

Eight CT bioscience projects get CI funding

Eight bioscience projects with ties to Yale, UConn, and Quinnipiac University will receive up to $30,000 under a state program aimed at bolstering the development of health technology. Connecticut Innovations announced the winners in the latest round of funding under its BioScience Pipeline Program more

By |January 25th, 2018|News|0 Comments

Pfizer in diagnostics deal with Foundation Medicine

Pfizer has struck a broad cancer companion diagnostic deal with Foundation Medicine. The alliance will see Foundation Medicine use pan-cancer test FoundationOne CDx as a companion diagnostic for Pfizer drugs. “The combination of our FDA-approved comprehensive genomic profiling platform and molecular information solutions, coupled with Pfizer’s robust oncology portfolio, enables us to enhance the impact of precision oncology to advance patient care,” Melanie Nallicheri, head of biopharma at Foundation Medicine, said in a statement. more

By |January 25th, 2018|News|0 Comments

UConn startups raise record-setting $60M in 2017

UConn reports that startups in its Technology Incubation Program (TIP) attracted a record $60 million in funding to help speed up their growth in 2017. TIP startups' gains in equity, debt, grant, and revenue funding amounted to almost $20 million more than the previous record of $39.9 million for debt and equity funding set in 2016, with most investment coming from out-of-state sources. more

By |January 25th, 2018|News|0 Comments

BI doubles input into venture fund to $300 million

Boehringer Ingelheim has announced it is more than doubling its input into the Boehringer Ingelheim Venture Fund to nearly $300 million. The corporate venture fund, previously funded at about $120 million, was created in 2010 and invests in new biotech companies and research. The increased funding will be used to invest in promising startup companies that focus on regenerative medicine, infectious diseases and digital health, the company announced. The fund will also double the number of investment managers. more

By |January 25th, 2018|News|0 Comments

Elidah gets $300K re urinary incontinence device

Monroe-based Elidah has received a National Science Foundation grant and a Department of Defense contract to further develop its neuromuscular stimulation technology to treat incontinence. The awards were $150,000 each. Elidah's Elitone device works by electrically stimulating the perineal tissue, causing the pelvic floor muscles to contract and strengthen over time. more

By |January 25th, 2018|News|0 Comments

CT Children’s invests in bioengineering company

Connecticut Children's Medical Center said it has invested in a Holliston, Mass.-based biotechnology company that's developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea. Biostage Inc. announced the funding on along with the closing of a private placement with a group of investors from China totaling about $4.1 million. more

By |January 25th, 2018|News|0 Comments

Thetis partners with UConn Health re bowel disease

Branford's Thetis is expanding its collaboration with a UConn Health scientist to further its search for a better treatment for inflammatory bowel disease (IBD), which impacts an estimated 1.6 million Americans. Fund recently raised will allow Thetis to expand a pilot study it recently conducted with UConn's Health's Daniel Rosenberg, chair of cancer biology and professor of medicine, among other titles. more

By |January 25th, 2018|News|0 Comments